|
1
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McCann J: Esophageal cancers: changing
character, increasing incidence. Natl Cancer Inst. 91:497–498.
1999. View Article : Google Scholar
|
|
4
|
Demeester SR: Epidemiology and biology of
esophageal cancer. Gastrointest Cancer Res. 3(Suppl 2): S2–S5.
2009.PubMed/NCBI
|
|
5
|
Brennecke J and Cohen SM: Towards a
complete description of the microRNA complement of animal genomes.
Genome Biol. 4:2282003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: microRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carthew RW and Sontheimer EJ: Origins and
mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rosenfeld N, Aharonov R, Meiri E, et al:
microRNAs accurately identify cancer tissue origin. Nat Biotechnol.
26:462–469. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liang Y, Ridzon D, Wong L and Chen C:
Characterization of microRNA expression profiles in normal human
tissues. BMC Genomics. 8:1662007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cho WC: OncomiRs: the discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xin SY, Feng XS, Zhou LQ, Sun JJ, Gao XL
and Yao GL: Reduced expression of circulating microRNA-218 in
gastric cancer and correlation with tumor invasion and prognosis.
World J Gastroenterol. 20:6906–6911. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao C, Zhang Z, Liu W, Xiao S, Gu W and Lu
H: Reduced microRNA-218 expression is associated with high nuclear
factor kappa B activation in gastric cancer. Cancer. 116:41–49.
2010.
|
|
17
|
Yu J, Wang Y, Dong R, Huang X, Ding S and
Qiu H: Circulating microRNA-218 was reduced in cervical cancer and
correlated with tumor invasion. J Cancer Res Clin Oncol.
138:671–674. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Venkataraman S, Birks DK, Balakrishnan I,
et al: microRNA 218 acts as a tumor suppressor by targeting
multiple cancer phenotype-associated genes in medulloblastoma. J
Biol Chem. 288:1918–1928. 2013. View Article : Google Scholar :
|
|
19
|
Zhang C, Ge S, Hu C, Yang N and Zhang J:
MiRNA-218, a new regulator of HMGB1, suppresses cell migration and
invasion in non-small cell lung cancer. Acta Biochim Biophys Sin
(Shanghai). 45:1055–1061. 2013. View Article : Google Scholar
|
|
20
|
Liu Y, Yan W, Zhang W, et al: miR-218
reverses high invasiveness of glioblastoma cells by targeting the
oncogenic transcription factor LEF1. Oncol Rep. 28:1013–1021.
2012.PubMed/NCBI
|
|
21
|
Prudnikova TY, Mostovich LA, Kashuba VI,
Ernberg I, Zabarovsky ER and Grigorieva EV: miRNA-218 contributes
to the regulation of D-glucuronyl C5-epimerase expression in normal
and tumor breast tissues. Epigenetics. 7:1109–1114. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang L, Li Q, Wang Q, Jiang Z and Zhang L:
Silencing of miRNA-218 promotes migration and invasion of breast
cancer via Slit2-Robo1 pathway. Biomed Pharmacother. 66:535–540.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li J, Ping Z and Ning H: miR-218 impairs
tumor growth and increases chemo-sensitivity to cisplatin in
cervical cancer. Int J Mol Sci. 13:16053–16064. 2012. View Article : Google Scholar
|
|
24
|
Yang M, Liu R, Sheng J, et al:
Differential expression profiles of microRNAs as potential
biomarkers for the early diagnosis of esophageal squamous cell
carcinoma. Oncol Rep. 29:169–176. 2013.
|
|
25
|
Andl CD, Mizushima T, Nakagawa H, et al:
Epidermal growth factor receptor mediates increased cell
proliferation, migration, and aggregation in esophageal
keratinocytes in vitro and in vivo. J Biol Chem. 278:1824–1830.
2003. View Article : Google Scholar
|
|
26
|
Sakai NS, Samia-Aly E, Barbera M and
Fitzgerald RC: A review of the current understanding and clinical
utility of miRNAs in esophageal cancer. Semin Cancer Biol.
23:512–521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luthra R, Singh RR, Luthra MG, et al:
microRNA-196a targets annexin A1: a microRNA-mediated mechanism of
annexin A1 downregulation in cancers. Oncogene. 27:6667–6678. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kan T, Sato F, Ito T, et al: The
miR-106b-25 polycistron, activated by genomic amplification,
functions as an oncogene by suppressing p21 and Bim.
Gastroenterology. 136:1689–1700. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee KH, Goan YG, Hsiao M, et al:
microRNA-373 (miR-373) post-transcriptionally regulates large tumor
suppressor, homolog 2 (LATS2) and stimulates proliferation in human
esophageal cancer. Exp Cell Res. 315:2529–2538. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fassan M, Volinia S, Palatini J, et al:
microRNA expression profiling in human Barrett’s carcinogenesis.
Int J Cancer. 129:1661–1670. 2011. View Article : Google Scholar
|
|
31
|
Zhang M, Zhou S, Zhang L, et al: miR-518b
is downregulated, and involved in cell proliferation and invasion
by targeting Rap1b in esophageal squamous cell carcinoma. FEBS
Lett. 586:3508–3521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Z, Qiao Q, Chen M, et al: miR-625
downregulation promotes proliferation and invasion in esophageal
cancer by targeting Sox2. FEBS Lett. 588:915–921. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang Y, Zang W, Du Y, et al: mir-655
upregulation suppresses cell invasion by targeting pituitary
tumor-transforming gene-1 in esophageal squamous cell carcinoma. J
Transl Med. 11:3012013. View Article : Google Scholar
|
|
34
|
Calin GA and Croce CM: microRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Manikandan J, Aarthi JJ, Kumar SD and
Pushparaj PN: Oncomirs: the potential role of non-coding microRNAs
in understanding cancer. Bioinformation. 2:330–334. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Song L, Huang Q, Chen K, et al: miR-218
inhibits the invasive ability of glioma cells by direct
downregulation of IKK-β. Biochem Biophys Res Commun. 402:135–140.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shi J, Yang L, Wang T, et al: miR-218 is
downregulated and directly targets SH3GL1 in childhood
medulloblastoma. Mol Med Rep. 8:1111–1117. 2013.PubMed/NCBI
|
|
38
|
Hassan MQ, Maeda Y, Taipaleenmaki H, et
al: miR-218 directs a Wnt signaling circuit to promote
differentiation of osteoblasts and osteomimicry of metastatic
cancer cells. J Biol Chem. 287:42084–42092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tie J, Pan Y, Zhao L, et al: miR-218
inhibits invasion and metastasis of gastric cancer by targeting the
Robo1 receptor. PLoS Genet. 6:e10008792010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yamamoto N, Kinoshita T, Nohata N, et al:
Tumor suppressive microRNA-218 inhibits cancer cell migration and
invasion by targeting focal adhesion pathways in cervical squamous
cell carcinoma. Int J Oncol. 42:1523–1532. 2013.PubMed/NCBI
|
|
41
|
Courtney KD, Corcoran RB and Engelman JA:
The PI3K pathway as drug target in human cancer. J Clin Oncol.
28:1075–1083. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Huang Y, Xi Q, Chen Y, et al: A dual
mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal
squamous cell carcinoma cells and sensitizes them to cisplatin.
Anticancer Drugs. 24:889–898. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Uesugi A, Kozaki K, Tsuruta T, et al: The
tumor suppressive microRNA miR-218 targets the mTOR component
Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res.
71:5765–5778. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Xiao ZD, Jiao CY, Huang HT, et al: miR-218
modulate hepatocellular carcinoma cell proliferation through PTEN/
AKT/PI3K pathway and HoxA10. Int J Clin Exp Pathol. 7:4039–4044.
2014.
|
